606 related articles for article (PubMed ID: 32326590)
21. Peptidylarginine Deiminase Isozyme-Specific PAD2, PAD3 and PAD4 Inhibitors Differentially Modulate Extracellular Vesicle Signatures and Cell Invasion in Two Glioblastoma Multiforme Cell Lines.
Uysal-Onganer P; MacLatchy A; Mahmoud R; Kraev I; Thompson PR; Inal JM; Lange S
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098295
[TBL] [Abstract][Full Text] [Related]
22. Peptidylarginine deiminase and deiminated proteins are detected throughout early halibut ontogeny - Complement components C3 and C4 are post-translationally deiminated in halibut (Hippoglossus hippoglossus L.).
Magnadóttir B; Bragason BT; Bricknell IR; Bowden T; Nicholas AP; Hristova M; Guðmundsdóttir S; Dodds AW; Lange S
Dev Comp Immunol; 2019 Mar; 92():1-19. PubMed ID: 30395876
[TBL] [Abstract][Full Text] [Related]
23. Extracellular Vesicles and Post-Translational Protein Deimination Signatures in Mollusca-The Blue Mussel (
Bowden TJ; Kraev I; Lange S
Biology (Basel); 2020 Nov; 9(12):. PubMed ID: 33255637
[TBL] [Abstract][Full Text] [Related]
24. Putative Roles for Peptidylarginine Deiminases in COVID-19.
Arisan ED; Uysal-Onganer P; Lange S
Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32629995
[TBL] [Abstract][Full Text] [Related]
25. Peptidylarginine deiminases and deiminated proteins at the epidermal barrier.
Cau L; Méchin MC; Simon M
Exp Dermatol; 2018 Aug; 27(8):852-858. PubMed ID: 29756256
[TBL] [Abstract][Full Text] [Related]
26. Peptidylarginine deiminases: novel drug targets for prevention of neuronal damage following hypoxic ischemic insult (HI) in neonates.
Lange S; Rocha-Ferreira E; Thei L; Mawjee P; Bennett K; Thompson PR; Subramanian V; Nicholas AP; Peebles D; Hristova M; Raivich G
J Neurochem; 2014 Aug; 130(4):555-62. PubMed ID: 24762056
[TBL] [Abstract][Full Text] [Related]
27. A Pilot Study on Peptidylarginine Deiminases and Protein Deimination in Animal Cancers across Vertebrate Species.
Inal JM; Hristova M; Lange S
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955829
[TBL] [Abstract][Full Text] [Related]
28. Peptidylarginine Deiminase Inhibitor Application, Using Cl-Amidine, PAD2, PAD3 and PAD4 Isozyme-Specific Inhibitors in Pancreatic Cancer Cells, Reveals Roles for PAD2 and PAD3 in Cancer Invasion and Modulation of Extracellular Vesicle Signatures.
Uysal-Onganer P; D'Alessio S; Mortoglou M; Kraev I; Lange S
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573274
[TBL] [Abstract][Full Text] [Related]
29. Peptidylarginine deiminases and extracellular vesicles: prospective drug targets and biomarkers in central nervous system diseases and repair.
Lange S
Neural Regen Res; 2021 May; 16(5):934-938. PubMed ID: 33229732
[TBL] [Abstract][Full Text] [Related]
30. Post-translational protein deimination in cod (Gadus morhua L.) ontogeny novel roles in tissue remodelling and mucosal immune defences?
Magnadóttir B; Hayes P; Hristova M; Bragason BT; Nicholas AP; Dodds AW; Guðmundsdóttir S; Lange S
Dev Comp Immunol; 2018 Oct; 87():157-170. PubMed ID: 29908202
[TBL] [Abstract][Full Text] [Related]
31. Plasma Extracellular Vesicle α-Synuclein Level in Patients with Parkinson's Disease.
Chung CC; Chan L; Chen JH; Hung YC; Hong CT
Biomolecules; 2021 May; 11(5):. PubMed ID: 34067663
[TBL] [Abstract][Full Text] [Related]
32. Complement component C4-like protein in Atlantic cod (Gadus morhua L.) - Detection in ontogeny and identification of post-translational deimination in serum and extracellular vesicles.
Lange S; Kraev I; Magnadóttir B; Dodds AW
Dev Comp Immunol; 2019 Dec; 101():103437. PubMed ID: 31288046
[TBL] [Abstract][Full Text] [Related]
33. Peptidylarginine Deiminases-Roles in Cancer and Neurodegeneration and Possible Avenues for Therapeutic Intervention via Modulation of Exosome and Microvesicle (EMV) Release?
Lange S; Gallagher M; Kholia S; Kosgodage US; Hristova M; Hardy J; Inal JM
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28587234
[TBL] [Abstract][Full Text] [Related]
34. Deimination and Peptidylarginine Deiminases in Skin Physiology and Diseases.
Méchin MC; Takahara H; Simon M
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31952341
[TBL] [Abstract][Full Text] [Related]
35. Citrullination and PAD Enzyme Biology in Type 1 Diabetes - Regulators of Inflammation, Autoimmunity, and Pathology.
Yang ML; Sodré FMC; Mamula MJ; Overbergh L
Front Immunol; 2021; 12():678953. PubMed ID: 34140951
[TBL] [Abstract][Full Text] [Related]
36. Deimination of myelin basic protein. 2. Effect of methylation of MBP on its deimination by peptidylarginine deiminase.
Pritzker LB; Joshi S; Harauz G; Moscarello MA
Biochemistry; 2000 May; 39(18):5382-8. PubMed ID: 10820009
[TBL] [Abstract][Full Text] [Related]
37. Plasma extracellular vesicles tau and β-amyloid as biomarkers of cognitive dysfunction of Parkinson's disease.
Chung CC; Chan L; Chen JH; Bamodu OA; Chiu HW; Hong CT
FASEB J; 2021 Oct; 35(10):e21895. PubMed ID: 34478572
[TBL] [Abstract][Full Text] [Related]
38. Peptidylarginine Deiminase Inhibitors Reduce Bacterial Membrane Vesicle Release and Sensitize Bacteria to Antibiotic Treatment.
Kosgodage US; Matewele P; Mastroianni G; Kraev I; Brotherton D; Awamaria B; Nicholas AP; Lange S; Inal JM
Front Cell Infect Microbiol; 2019; 9():227. PubMed ID: 31316918
[TBL] [Abstract][Full Text] [Related]
39. Peptidylarginine Deiminase (PAD) and Post-Translational Protein Deimination-Novel Insights into Alveolata Metabolism, Epigenetic Regulation and Host-Pathogen Interactions.
Kristmundsson Á; Erlingsdóttir Á; Lange S
Biology (Basel); 2021 Feb; 10(3):. PubMed ID: 33653015
[TBL] [Abstract][Full Text] [Related]
40. Insights into peptidylarginine deiminase expression and citrullination pathways.
Yu K; Proost P
Trends Cell Biol; 2022 Sep; 32(9):746-761. PubMed ID: 35197210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
